News

DoseEdge is the pharmacy workflow management tool that verifies the use of correct drugs, diluents and concentrations in the compounding of IV, chemo, TPN and oral liquid doses.

Intelleflex claimed that the new HMR-9090 Handheld Reader and FMR-6000 Fixed Reader work with the company’s tags to enable wireless, on-demand, product-level monitoring by providing the ability to

Advanced Proteome Therapeutics (APC) has entered into an agreement for a feasibility study with a global pharmaceutical company interested in evaluating APC’s proprietary crosslinking technologies. As per the

Clinical Data said that the issued patent, which will expire in June 2022, covers Vilazodone HC1 in Form IV, its process of preparation and method of treatment therewith.

Sponsored by the US Army Research Office, the grant will allow PolyMedix to conduct further testing on antimicrobial compounds which PolyMedix identified under the initial Phase 1 contract.

Orban Biotech said that the QTDP covers funding for a therapeutic insulin B chain vaccine to treat type 1 diabetes mellitus. The company claims that its insulin B

AVEO Pharma claims that Tivozanib, an investigational new drug, is a highly potent and selective inhibitor of VEGF receptors 1, 2 and 3, exhibiting picomolar inhibitory activity against

In the Phase I trial, ReNeuron’s ReN001stem cell therapy is being administered to stroke patients who have been left disabled by an ischaemic stroke. The PISCES study (Pilot

VR040 is Vectura’s proprietary formulation of apomorphine, delivered to the bloodstream by inhalation through the lungs using the company’s proprietary dry powder inhalation (DPI) technology. The results of